Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Profit & Loss
Glaxosmithkline Pharmaceuticals Ltd
Industry : Pharmaceuticals - Multinational
BSE Code
ISIN Demat
Book Value(
)
500660
INE159A01016
91.3566062
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
GLAXO
55.81
35471.08
EPS(TTM)
Face Value(
)
Div & Yield %:
37.52
10
1.53
Particulars(INCOME)
Mar 2023
(
Cr)
Mar 2022
(
Cr)
Mar 2021
(
Cr)
Mar 2020
(
Cr)
Mar 2019
(
Cr)
Mar 2018
(
Cr)
Sales Turnover
3216.34
3217.51
2920.48
3224.68
3128.53
2895.88
Excise Duty
0.00
0.00
0.00
0.00
0.00
24.19
Net Sales
3216.34
3217.51
2920.48
3224.68
3128.53
2871.69
Other Income
114.96
1423.27
217.71
624.37
149.56
71.32
Stock Adjustments
-67.25
-13.83
26.12
35.43
-25.57
57.94
Total Income
3264.05
4626.95
3164.31
3884.48
3252.52
3000.95
EXPENDITURE :
Raw Materials
1182.78
1281.91
1275.49
1343.30
1327.96
1298.69
Power & Fuel Cost
29.60
27.83
26.08
33.36
27.94
26.44
Employee Cost
594.99
610.23
616.16
628.55
537.20
523.40
Other Manufacturing Expenses
99.05
120.14
110.59
107.88
115.19
110.55
Selling & Administrative Expenses
370.30
343.57
242.00
376.68
381.32
357.82
Miscellaneous Expenses
84.32
85.69
287.75
983.19
150.08
104.29
Less : Pre-operative Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
2361.04
2469.38
2558.07
3472.96
2539.68
2421.18
Operating Profit
903.01
2157.57
606.24
411.52
712.85
579.76
Interest
1.81
1.99
3.53
6.34
0.55
0.19
Gross Profit
901.20
2155.58
602.71
405.18
712.30
579.57
Depreciation
65.77
68.19
78.60
82.68
48.59
37.99
Profit Before Tax
835.43
2087.39
524.11
322.50
663.71
541.58
Tax
246.05
407.36
158.67
260.17
192.82
204.34
Fringe Benefit tax
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax
-18.37
-10.49
7.87
-47.72
45.52
-14.74
Reported Net Profit
607.75
1690.53
357.57
110.05
425.36
351.99
Extraordinary Items
21.05
11.18
-117.79
-87.09
4.04
9.57
Adjusted Net Profit
586.70
1679.35
475.36
197.14
421.32
342.42
Adjustment below Net Profit
-17.08
-11.05
0.00
-73.62
-64.12
-51.73
P & L Balance brought forward
1745.02
562.71
882.77
1177.99
1113.21
1067.06
Statutory Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
1524.66
508.22
677.62
338.81
296.46
254.11
P & L Balance carried down
811.03
1733.98
562.71
875.62
1177.99
1113.21
Dividend
0.00
0.00
0.00
0.00
0.00
296.46
Preference Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend %
320.00
900.00
300.00
400.00
200.00
350.00
Dividend Per Share(Rs)
32.00
90.00
30.00
40.00
20.00
35.00
Earnings Per Share-Unit Curr
35.88
99.79
21.11
6.50
25.11
41.56
Earnings Per Share(Adj)-Unit Curr
35.88
99.79
21.11
6.50
25.11
20.78
Book Value-Unit Curr
103.48
158.06
88.37
108.62
126.47
245.56
Book Value(Adj)-Unit Curr
103.48
158.06
88.37
108.62
126.47
122.78